NLM Logo

N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide MeSH Supplementary Concept Data 2023


MeSH Supplementary
N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide
Unique ID
C570037
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C570037
Entry Term(s)
N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-(Z)-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide
SIM 010603
SIM-010603
SIM010603
tafetinib
Registry Number
0
Heading Mapped to
*Ethylamines
*Indoles
Frequency
4
Note
a receptor tyrosine kinase inhibitor with antiangiogenic and antineoplastic activities; structure in first source
Source
Cancer Chemother Pharmacol. 2012 Jan;69(1):173-83.
Indexing Information
Antineoplastic Agents
Protein Kinase Inhibitors
Date of Entry
2012/02/15
Revision Date
2023/07/17
N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide Preferred
tafetinib Narrower
N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-(Z)-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide
SIM 010603 Narrower
page delivered in 0.007s